Immune Thrombocytopenic Purpura: New Biological Therapy of an Old Disease

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|22|16|1956-1962

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.22, Iss.16, 2015-05, pp. : 1956-1962

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dexamethasone effective in immune thrombocytopenic purpura

By  

Inpharma, Vol. 1, Iss. 1403, 2003-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Plasma Thrombospondin in Immune Thrombocytopenic Purpura

By Özcebe Oİ   Karakuş S   Haznedaroğlu İC   Göker H   Kosar A   Koçoğlu H   Büyükaşik Y   Sayinalp N   Kirazli Ş  

The Journal of International Medical Research, Vol. 30, Iss. 1, 2002-01 ,pp. : 52-55

Field House Publishing

Access to resources Recommend Favorite

Natalizumab: Immune thrombocytopenic purpura: case report

By  

Reactions Weekly, Vol. 1, Iss. 1370, 2011-01 ,pp. : 28-29

Adis International

Access to resources Recommend Favorite

Treatment of Immune Thrombocytopenic Purpura in Children: Current Concepts

By Shad Aziza T.  

Pediatric Drugs, Vol. 7, Iss. 5, 2005-01 ,pp. : 325-336

Adis International

Access to resources Recommend Favorite

Immune thrombocytopenic purpura – current management practices

By Sandler S Gerald   Tutuncuoglu S Osman  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 12, 2004-12 ,pp. : 2515-2527

Informa Healthcare

Access to resources Recommend Favorite